Latest News About Orthohantavirus

Here’s the latest on orthohantavirus based on recent sources I can summarize for you.

• A new orthohantavirus variant linked to a fatal hantavirus pulmonary syndrome case was genetically characterized in northwestern Argentina in 2024, highlighting ongoing diversification and the importance of molecular surveillance in non-endemic regions. This underscores that the disease can appear outside traditional hotspots and that rapid laboratory confirmation often relies on serology and molecular tests.[1]

• Diagnostics and surveillance discussions continue to emphasize a mix of serology (IgM/IgG), RT-PCR for viral RNA, and, when possible, viral culture or immunohistochemistry for confirmation, with international coordination efforts improving standardized protocols across regions. These efforts aim to improve comparability of case definitions and testing strategies globally.[2]

• Public health trackers and surveillance platforms have emerged to monitor hantavirus activity in real time, including curves of case counts and strain information, though coverage and reliability vary by region and outbreak context; one example tracks a cluster related to an expedition cruise with Andes orthohantavirus as the agent, illustrating the potential for person-to-person transmission in specific variants though such incidence remains rare.[3]

• Broad reviews and overviews remain useful for context, noting that orthohantaviruses are rodent-borne and cause diseases such as hantavirus pulmonary syndrome (HPS) in the Americas and hemorrhagic fever with renal syndrome (HFRS) in Eurasia, with ongoing discovery of new lineages in rodent reservoirs that may impact future human infections.[7][8]

• General public-facing information warns against unnecessary alarm while encouraging adherence to standard preventive measures (rodent control, avoiding exposure to rodent excreta in endemic areas), given the zoonotic and sporadic nature of most orthohantavirus infections.[5][7]

If you’d like, I can pull the most current regional updates (e.g., US, Latin America, or Europe) and summarize any new case definitions or guidance from health authorities. I can also provide a concise, citable one-page briefing with key takeaways and references.